Raia Drogasil S.A. (OTCMKTS:RADLY) Sees Large Increase in Short Interest

Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 402,126 shares, a growth of 22,315.1% from the June 30th total of 1,794 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 75,614 shares, the days-to-cover ratio is currently 5.3 days.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Check Out Our Latest Stock Report on RADLY

Raia Drogasil Stock Performance

Shares of OTCMKTS:RADLY traded down $0.08 during trading on Friday, reaching $3.53. The stock had a trading volume of 1,172 shares, compared to its average volume of 57,192. The business has a fifty day moving average price of $3.57 and a 200-day moving average price of $4.28. Raia Drogasil has a fifty-two week low of $2.33 and a fifty-two week high of $5.34.

About Raia Drogasil

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Featured Stories

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.